Cancer IVD Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021-2026

Report Code: HCR 97993 Report Format: PDF + Excel (Delivery in 48 Hrs)

Cancer IVD Market Overview

Cancer IVD Market size was valued at $17,728 million in 2020 and is anticipated to reach $22,430 million by the end of 2026 growing at a CAGR of 6.0% during the forecast period 2021-2026. The surgical electrical stapler’s industry growth rate is attributed to the rising incidences of chronic lifestyle diseases across the globe and is anticipated to bring new opportunities. Cancer In vitro diagnostics (IVD) are medical devices, which require the use of assays and reagents to diagnose a medical condition. Moreover, these instruments analyze body fluids and tissue samples that are collected from a patient. 

In addition, there are a variety of in vitro diagnostic instruments that work with various techniques such as immunodiagnostics, tissue diagnostics, hematology, and molecular diagnostics. Surgical staplers are instruments used to aid in the physical modification of biological tissue or the rapid recovery of internal and external body tissues. Furthermore, developments in genomics and proteomics, as well as increased investment in developing countries are bringing a new range of condition-specific markers and tests to market. 

On the contrary, inadequate returning policy and stringent regulatory approval framework are restraining the growth of this market. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies is anticipated to open growth avenues for the Cancer IVD market during the forecast period 2021-2026.

Report Coverage

The report: “Cancer IVD Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cancer IVD Market:
By Product and Services: Reagents and Kits, Instruments, Data Management Software, and Services.
By Technology: Clinical Chemistry, Immunochemistry/Immunoassays, Hematology, Coagulation and Hemostasis, Microbiology, Molecular Diagnostics, and Others.
By End-Users: Hospitals, Laboratories, Academics, Point-Of-Care Testing, Patient Self-Testing, and Others.
By Geography: North America (U.S, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Others), APAC (China, Japan, India, South Korea, Australia, and Others), South America(Brazil, Argentina, and Others) and RoW (Middle East and Africa).

Key Takeaways

  • North America dominated the Cancer IVD market with a share of 35.60% in the year 2020.        
  • The factors such as growing aging population and increasing usage of point-of-care testing and personalized medicine are among the major factor projected to impel growth of Cancer IVD market.
  • Additionally, factors such as development of automated in vitro diagnostic systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnosis are set to create opportunities paving a way for the growth in the market during forecast period 2021-2026.

Global Cancer IVD Market, By Technology 2020(%)

Global Cancer IVD Market

For more details on this report - Request for Sample

Cancer IVD Market Segment Analysis - By Product & Services

In 2020, on the basis of product and services, reagents segment accounted for the largest segmental revenue of the Cancer IVD market. The reagents segment held the largest market on account of the fact that there is an increasing demand for rapid, accurate, and sensitive devices. Furthermore, their wide usage in cancer in-vitro diagnostic testing, increase in demand for self-testing and point-of-care products, and rise in the number of R&D initiatives pertaining to reagents are expected to aid market growth.

On the contrary, services segment is projected to witness healthy growth throughout the forecast period 2021-2026 with a CAGR of 6.80% as a result of the various programming interfaces used for operating cancer diagnostic instruments, conducting analysis, and interpreting results. Many instruments, including point-of-care analyzers, laboratory-based analyzers, portable personal in vitro diagnostics, and others, use in vitro diagnostic software. In addition, increasing adoption of in-vitro diagnostic systems with analyzer software at diagnostic centers is anticipated to fuel market growth during the forecast period 2021-2026.

Cancer IVD Market Segment Analysis - By End Users

On the basis of end use, hospitals segment accounted for the largest segmental revenue of the Cancer IVD market in 2020 as there is an increase in hospitalization as doctors require diagnostic interpretation for further treatment of cancer. Diagnostic centers often partner with hospitals; as a result, hospitals often have their own diagnostic setup. Furthermore, ongoing healthcare infrastructure growth is projected to boost current hospital facilities. The market for cancer in-vitro diagnostic tests in hospitals is developing.

On the other hand, patient self-testing segment is projected to dominate over 2021-2026 with a CAGR of 6.50%. The patient self-testing are to witness a healthy growth owing to the rising geriatric population and increasing demand for home care in vitro diagnostic devices. Moreover, convenient and supportive care provided at home by licensed healthcare professionals also reduces hospital visits. All these factors are to drive the segmental market growth.

Cancer IVD Market Segment Analysis - By Geography

North America is the major region dominating the Cancer IVD market with a market share of 35.60% in the year 2020. This can be attributed to the use of advanced technologies and IVD methods are increasing the number of total surgeries performed in this region, the local presence of global players, and FDA approval for non-invasive surgeries in North America have fueled the regional market. Moreover, with recent developments in in-vitro diagnostics surgeries, special devices are designed for cancer treatment. Hence, it has become the responsibility of surgeons to acquire prerequisite knowledge of these devices thereby, indirectly driving regional market growth.

During the forecast period 2021-2026, however, Asia-Pacific is anticipated to be the fastest region. Asia Pacific consists of developing and developed economies. The industry is forecast to be fueled by increasing healthcare awareness and patients seeking early diagnosis in the area, as well as a high prevalence of chronic diseases. Apart from these, the rising affordability rates and improving regulatory scenario are estimated to propel the market in the region.

Cancer IVD Market Drivers

Rising Prevalence Of Cancer Coupled With Increasing Product Approvals And Product Launches

The cancer IVD market is poised to receive upswing owing to rising prevalence of cancer coupled with increasing product approvals and product launches. The rising prevalence of cancer and autoimmune diseases is poised to drive the global in-vitro diagnostics market. The increasing product launches in the region is the major factor expected to propel the market growth owing to support from regulatory authorities as well as other government organizations are other growth augmenting factors that will affect the surgical electric staplers screening market.

Cancer IVD Market Challenges

Unfavorable Reimbursement Scenario

Despite several drivers, one of the major factor hindering is inadequate reimbursement which is restraining the population in opting such treatment facilities. Moreover, regulatory and legal requirements applied to various IVD devices in the US and European countries are becoming more stringent and are also playing a vital role in challenging the regional market growth.

Cancer IVD Market Landscape

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Cancer IVD Market. In 2020, Cancer IVD market share is fragmented by the top ten players present in the market. Cancer IVD Market top 10 companies are Roche Diagnostics, Abbott Laboratories, Inc., Becton, Dickson and Company, Ortho-Clinical Diagnostics, Johnson and Johnson, Danaher Corporation, Thermo Fisher Scientific, Inc, Siemens Healthcare, Bio-Rad Laboratories, Inc., Sysmex Corporation, bioMérieux and others.

Acquisitions/Product Launches

  • In January 2021, Illumina revealed plans to step up its cancer detection efforts by launching a new in vitro diagnostic (IVD) test and bolstering its oncology-focused companion diagnostic (CDx) collaborations—as well as plans to launch a new cloud-based bioinformatics data platform.
  • In February, 2020 – Biocare Medical announced the launch of seven novel IVD IHC antibody markers for clinical diagnostics and research applications. The most recent launch focuses on several immuno-oncology markers, critical in aiding early-stage cancer drug developments and patient treatment.

Relevant Reports:

Report Code: HCR 1226

Report Code: HCR 0195

For more Lifesciences and Healthcare Market reports, please click here
1. Cancer IVD Market - Overview
    1.1 Definitions and Scope
2. Cancer IVD Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by End Users
    2.4 Key trends by Geography
3. Cancer IVD Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Cancer IVD Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Cancer IVD Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Cancer IVD Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Cancer IVD Market – Strategic Analysis
    7.1 Value Chain Analysis 
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Cancer IVD Market - By Product & Services (Market Size –$Million/$Billion)
    8.1 Instruments
        8.1.1 Fully-automated Instruments
        8.1.2 Semi-automated Instruments
        8.1.3 Others
    8.2 Reagents and Kits
    8.3 Data Management System/Software
    8.4 Services
9. Cancer IVD Market - By Technology (Market Size –$Million/$Billion)
    9.1 Clinical Chemistry
    9.2 Immunochemistry/Immunoassays
    9.3 Hematology
    9.4 Coagulation and Hemostasis
    9.5 Microbiology
    9.6 Molecular Diagnostics
    9.7 Others
10. Cancer IVD Market - By End-Users (Market Size –$Million/$Billion)
    10.1 Laboratories
    10.2 Hospitals
    10.3 Academic Institutes
    10.4 Point-of-care Testing
    10.5 Patient Self-testing
    10.6 Others
11. Cancer IVD Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Russia
        11.2.5 Italy
        11.2.6 Spain
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6  Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Others
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
        11.5.3 South America
12. Cancer IVD Market - Entropy
13.  Cancer IVD Market – Industry/Segment Competition Landscape Premium
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Cancer IVD Market – Key Company List by Country Premium Premium
15. Cancer IVD Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10  Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global CANCER IVD MARKET, BY PRODUCT TYPE Market 2019-2024 ($M)
1.1 Reagents Market 2019-2024 ($M) - Global Industry Research
1.2 Instruments Market 2019-2024 ($M) - Global Industry Research
1.3 Software and Services Market 2019-2024 ($M) - Global Industry Research
2.Global CANCER IVD MARKET, BY TECHNIQUE Market 2019-2024 ($M)
2.1 Blood Testing Market 2019-2024 ($M) - Global Industry Research
2.2 Tissue Diagnostics Market 2019-2024 ($M) - Global Industry Research
3.Global CANCER IVD MARKET, BY CANCER TYPE Market 2019-2024 ($M)
3.1 Breast Cancer Market 2019-2024 ($M) - Global Industry Research
3.2 Colorectal Cancer Market 2019-2024 ($M) - Global Industry Research
3.3 Lung Cancer Market 2019-2024 ($M) - Global Industry Research
3.4 Prostate Cancer Market 2019-2024 ($M) - Global Industry Research
4.Global CANCER IVD MARKET, BY END USER Market 2019-2024 ($M)
4.1 Standalone Laboratory Market 2019-2024 ($M) - Global Industry Research
4.2 Hospitals Market 2019-2024 ($M) - Global Industry Research
4.3 Academic and Medical Schools Market 2019-2024 ($M) - Global Industry Research
5.Global CANCER IVD MARKET, BY PRODUCT TYPE Market 2019-2024 (Volume/Units)
5.1 Reagents Market 2019-2024 (Volume/Units) - Global Industry Research
5.2 Instruments Market 2019-2024 (Volume/Units) - Global Industry Research
5.3 Software and Services Market 2019-2024 (Volume/Units) - Global Industry Research
6.Global CANCER IVD MARKET, BY TECHNIQUE Market 2019-2024 (Volume/Units)
6.1 Blood Testing Market 2019-2024 (Volume/Units) - Global Industry Research
6.2 Tissue Diagnostics Market 2019-2024 (Volume/Units) - Global Industry Research
7.Global CANCER IVD MARKET, BY CANCER TYPE Market 2019-2024 (Volume/Units)
7.1 Breast Cancer Market 2019-2024 (Volume/Units) - Global Industry Research
7.2 Colorectal Cancer Market 2019-2024 (Volume/Units) - Global Industry Research
7.3 Lung Cancer Market 2019-2024 (Volume/Units) - Global Industry Research
7.4 Prostate Cancer Market 2019-2024 (Volume/Units) - Global Industry Research
8.Global CANCER IVD MARKET, BY END USER Market 2019-2024 (Volume/Units)
8.1 Standalone Laboratory Market 2019-2024 (Volume/Units) - Global Industry Research
8.2 Hospitals Market 2019-2024 (Volume/Units) - Global Industry Research
8.3 Academic and Medical Schools Market 2019-2024 (Volume/Units) - Global Industry Research
9.North America CANCER IVD MARKET, BY PRODUCT TYPE Market 2019-2024 ($M)
9.1 Reagents Market 2019-2024 ($M) - Regional Industry Research
9.2 Instruments Market 2019-2024 ($M) - Regional Industry Research
9.3 Software and Services Market 2019-2024 ($M) - Regional Industry Research
10.North America CANCER IVD MARKET, BY TECHNIQUE Market 2019-2024 ($M)
10.1 Blood Testing Market 2019-2024 ($M) - Regional Industry Research
10.2 Tissue Diagnostics Market 2019-2024 ($M) - Regional Industry Research
11.North America CANCER IVD MARKET, BY CANCER TYPE Market 2019-2024 ($M)
11.1 Breast Cancer Market 2019-2024 ($M) - Regional Industry Research
11.2 Colorectal Cancer Market 2019-2024 ($M) - Regional Industry Research
11.3 Lung Cancer Market 2019-2024 ($M) - Regional Industry Research
11.4 Prostate Cancer Market 2019-2024 ($M) - Regional Industry Research
12.North America CANCER IVD MARKET, BY END USER Market 2019-2024 ($M)
12.1 Standalone Laboratory Market 2019-2024 ($M) - Regional Industry Research
12.2 Hospitals Market 2019-2024 ($M) - Regional Industry Research
12.3 Academic and Medical Schools Market 2019-2024 ($M) - Regional Industry Research
13.South America CANCER IVD MARKET, BY PRODUCT TYPE Market 2019-2024 ($M)
13.1 Reagents Market 2019-2024 ($M) - Regional Industry Research
13.2 Instruments Market 2019-2024 ($M) - Regional Industry Research
13.3 Software and Services Market 2019-2024 ($M) - Regional Industry Research
14.South America CANCER IVD MARKET, BY TECHNIQUE Market 2019-2024 ($M)
14.1 Blood Testing Market 2019-2024 ($M) - Regional Industry Research
14.2 Tissue Diagnostics Market 2019-2024 ($M) - Regional Industry Research
15.South America CANCER IVD MARKET, BY CANCER TYPE Market 2019-2024 ($M)
15.1 Breast Cancer Market 2019-2024 ($M) - Regional Industry Research
15.2 Colorectal Cancer Market 2019-2024 ($M) - Regional Industry Research
15.3 Lung Cancer Market 2019-2024 ($M) - Regional Industry Research
15.4 Prostate Cancer Market 2019-2024 ($M) - Regional Industry Research
16.South America CANCER IVD MARKET, BY END USER Market 2019-2024 ($M)
16.1 Standalone Laboratory Market 2019-2024 ($M) - Regional Industry Research
16.2 Hospitals Market 2019-2024 ($M) - Regional Industry Research
16.3 Academic and Medical Schools Market 2019-2024 ($M) - Regional Industry Research
17.Europe CANCER IVD MARKET, BY PRODUCT TYPE Market 2019-2024 ($M)
17.1 Reagents Market 2019-2024 ($M) - Regional Industry Research
17.2 Instruments Market 2019-2024 ($M) - Regional Industry Research
17.3 Software and Services Market 2019-2024 ($M) - Regional Industry Research
18.Europe CANCER IVD MARKET, BY TECHNIQUE Market 2019-2024 ($M)
18.1 Blood Testing Market 2019-2024 ($M) - Regional Industry Research
18.2 Tissue Diagnostics Market 2019-2024 ($M) - Regional Industry Research
19.Europe CANCER IVD MARKET, BY CANCER TYPE Market 2019-2024 ($M)
19.1 Breast Cancer Market 2019-2024 ($M) - Regional Industry Research
19.2 Colorectal Cancer Market 2019-2024 ($M) - Regional Industry Research
19.3 Lung Cancer Market 2019-2024 ($M) - Regional Industry Research
19.4 Prostate Cancer Market 2019-2024 ($M) - Regional Industry Research
20.Europe CANCER IVD MARKET, BY END USER Market 2019-2024 ($M)
20.1 Standalone Laboratory Market 2019-2024 ($M) - Regional Industry Research
20.2 Hospitals Market 2019-2024 ($M) - Regional Industry Research
20.3 Academic and Medical Schools Market 2019-2024 ($M) - Regional Industry Research
21.APAC CANCER IVD MARKET, BY PRODUCT TYPE Market 2019-2024 ($M)
21.1 Reagents Market 2019-2024 ($M) - Regional Industry Research
21.2 Instruments Market 2019-2024 ($M) - Regional Industry Research
21.3 Software and Services Market 2019-2024 ($M) - Regional Industry Research
22.APAC CANCER IVD MARKET, BY TECHNIQUE Market 2019-2024 ($M)
22.1 Blood Testing Market 2019-2024 ($M) - Regional Industry Research
22.2 Tissue Diagnostics Market 2019-2024 ($M) - Regional Industry Research
23.APAC CANCER IVD MARKET, BY CANCER TYPE Market 2019-2024 ($M)
23.1 Breast Cancer Market 2019-2024 ($M) - Regional Industry Research
23.2 Colorectal Cancer Market 2019-2024 ($M) - Regional Industry Research
23.3 Lung Cancer Market 2019-2024 ($M) - Regional Industry Research
23.4 Prostate Cancer Market 2019-2024 ($M) - Regional Industry Research
24.APAC CANCER IVD MARKET, BY END USER Market 2019-2024 ($M)
24.1 Standalone Laboratory Market 2019-2024 ($M) - Regional Industry Research
24.2 Hospitals Market 2019-2024 ($M) - Regional Industry Research
24.3 Academic and Medical Schools Market 2019-2024 ($M) - Regional Industry Research
25.MENA CANCER IVD MARKET, BY PRODUCT TYPE Market 2019-2024 ($M)
25.1 Reagents Market 2019-2024 ($M) - Regional Industry Research
25.2 Instruments Market 2019-2024 ($M) - Regional Industry Research
25.3 Software and Services Market 2019-2024 ($M) - Regional Industry Research
26.MENA CANCER IVD MARKET, BY TECHNIQUE Market 2019-2024 ($M)
26.1 Blood Testing Market 2019-2024 ($M) - Regional Industry Research
26.2 Tissue Diagnostics Market 2019-2024 ($M) - Regional Industry Research
27.MENA CANCER IVD MARKET, BY CANCER TYPE Market 2019-2024 ($M)
27.1 Breast Cancer Market 2019-2024 ($M) - Regional Industry Research
27.2 Colorectal Cancer Market 2019-2024 ($M) - Regional Industry Research
27.3 Lung Cancer Market 2019-2024 ($M) - Regional Industry Research
27.4 Prostate Cancer Market 2019-2024 ($M) - Regional Industry Research
28.MENA CANCER IVD MARKET, BY END USER Market 2019-2024 ($M)
28.1 Standalone Laboratory Market 2019-2024 ($M) - Regional Industry Research
28.2 Hospitals Market 2019-2024 ($M) - Regional Industry Research
28.3 Academic and Medical Schools Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Cancer IVD Market Revenue, 2019-2024 ($M)
2.Canada Cancer IVD Market Revenue, 2019-2024 ($M)
3.Mexico Cancer IVD Market Revenue, 2019-2024 ($M)
4.Brazil Cancer IVD Market Revenue, 2019-2024 ($M)
5.Argentina Cancer IVD Market Revenue, 2019-2024 ($M)
6.Peru Cancer IVD Market Revenue, 2019-2024 ($M)
7.Colombia Cancer IVD Market Revenue, 2019-2024 ($M)
8.Chile Cancer IVD Market Revenue, 2019-2024 ($M)
9.Rest of South America Cancer IVD Market Revenue, 2019-2024 ($M)
10.UK Cancer IVD Market Revenue, 2019-2024 ($M)
11.Germany Cancer IVD Market Revenue, 2019-2024 ($M)
12.France Cancer IVD Market Revenue, 2019-2024 ($M)
13.Italy Cancer IVD Market Revenue, 2019-2024 ($M)
14.Spain Cancer IVD Market Revenue, 2019-2024 ($M)
15.Rest of Europe Cancer IVD Market Revenue, 2019-2024 ($M)
16.China Cancer IVD Market Revenue, 2019-2024 ($M)
17.India Cancer IVD Market Revenue, 2019-2024 ($M)
18.Japan Cancer IVD Market Revenue, 2019-2024 ($M)
19.South Korea Cancer IVD Market Revenue, 2019-2024 ($M)
20.South Africa Cancer IVD Market Revenue, 2019-2024 ($M)
21.North America Cancer IVD By Application
22.South America Cancer IVD By Application
23.Europe Cancer IVD By Application
24.APAC Cancer IVD By Application
25.MENA Cancer IVD By Application
26.Alere Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Bayer AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Becton, Dickinson and Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.bioMrieux, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Bio-Rad Laboratories, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Danaher Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.F. Hoffmann-La Roche AG, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Sysmex Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Thermo Fisher Scientific, Sales /Revenue, 2015-2018 ($Mn/$Bn)